• Users Online: 7435
  • Print this page
  • Email this page
Year : 2018  |  Volume : 7  |  Issue : 1  |  Page : 2-6

Displaced intra-articular calcaneal fractures treated with open reduction and internal fixation and bone void filling with an injectable calcium sulfate/hydroxyapatite bone graft substitute: A series of 18 patients

1 Department of Orthopedic Surgery and Traumatology, Santa Chiara Hospital, Trento, Italy
2 Department of Radiology, Santa Chiara Hospital, Trento, Italy

Correspondence Address:
Dr. Damiano Papadia
Department of Orthopedic Surgery and Traumatology, Santa Chiara Hospital, Largo Medaglie D'oro, 9, 38122 Trento
Login to access the Email id

Source of Support: None, Conflict of Interest: None

DOI: 10.4103/atr.atr_21_18

Rights and Permissions

Background: There is an ongoing debate if bone graft substitutes (BGSs) are beneficial in the treatment of displaced intra-articular calcaneal fractures (DIACFs). The purpose of this study was to evaluate the effect of an injectable calcium sulfate/hydroxyapatite BGS (CERAMENTTM iBONE VOID FILLER, BONESUPPORT AB, Lund, Sweden) in internal fixation of calcaneal fractures. Methods: The records of patients presenting with calcaneal fractures type Sanders III and IV and treated with internal fixation plus BGS were reviewed. Radiographs were analyzed using different measurements (including Böhler's angle and calcaneal facet height). The clinical outcome was evaluated using the American Orthopaedic Foot and Ankle Society (AOFAS) Ankle-Hindfoot Scale. Results: A total of 20 fractures were available for radiographic and clinical examination at a minimum follow-up of 12 months. No decrease in Böhler's angle was recorded in six fractures, a reduction of <5° in 6 and of more than 5° in 8 fractures. In all fractures, the BGS was completely resorbed at 12 months on radiographs. The AOFAS score was on an average 89.8 (range, 68–99) at 1-year follow-up and indicated an excellent outcome in 11, a good outcome in 8, and a fair outcome in 1 fracture. Conclusions: The study results support the use of an injectable, in situ hardening calcium sulfate/hydroxyapatite BGS in DIACFs. The BGS is easy and safe to use as an augment to open reduction and internal fixation.

Print this article     Email this article
 Next article
 Previous article
 Table of Contents

 Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
 Related articles
 Citation Manager
 Access Statistics
 Reader Comments
 Email Alert *
 Add to My List *
 * Requires registration (Free)

 Article Access Statistics
    PDF Downloaded705    
    Comments [Add]    
    Cited by others 1    

Recommend this journal